Vioquest Pharmaceutl (VOQP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 40 | 60 | 40 | 10 |
| Receivables | 80 | 40 | 80 | 100 | 60 |
| Inventories | 340 | 340 | 390 | 330 | 420 |
| Other current assets | -160 | -150 | -170 | -150 | -200 |
| TOTAL | $270 | $270 | $360 | $320 | $290 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 15 | 17 | 20 | 20 | 30 |
| TOTAL | $15 | $17 | $20 | $20 | $30 |
| Total Assets | $290 | $300 | $400 | $380 | $360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3 | 30 | 6 | 6 |
| Accounts payable and accrued liabilities | 40 | 40 | 60 | 60 | 120 |
| Accrued Expenses | 30 | 30 | 30 | 30 | 40 |
| TOTAL | $130 | $140 | $160 | $130 | $280 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 3 | 30 | 10 |
| TOTAL | $N/A | $N/A | $3 | $30 | $10 |
| Total Liabilities | $130 | $140 | $163 | $160 | $290 |
| Shareholders' Equity | |||||
| Common Shares | 4,470 | 4,470 | 4,470 | 4,280 | 4,260 |
| Retained earnings | -4,700 | -4,700 | -4,630 | -4,620 | -4,620 |
| Other shareholders' equity | 390 | 390 | 390 | 540 | 420 |
| TOTAL | $160 | $160 | $230 | $200 | $60 |
| Total Liabilities And Equity | $290 | $300 | $393 | $360 | $350 |